Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region

Virology

Volumn 358, Issue 2, 2007, Pages 266-272

  Kondo, Kazunari ^a,b   Ishii, Yoshiyuki ^a   Ochi, Hiroyuki ^a,b   Matsumoto, Tamae ^a   Yoshikawa, Hiroyuki ^b   Kanda, Tadahito ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

HPV16; Minor capsid protein L2; Neutralization epitope

Indexed keywords

CAPSID PROTEIN; SYNTHETIC PEPTIDE;

AMINO ACID SEQUENCE; ARTICLE; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 58; IMMUNIZATION; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; RABBIT; VIRUS NEUTRALIZATION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; ANTIGENS, VIRAL; CAPSID PROTEINS; CROSS REACTIONS; EPITOPES; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; IMMUNE SERA; IMMUNIZATION; INJECTIONS, SUBCUTANEOUS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PEPTIDES; RABBITS; VACCINES, SYNTHETIC;

HUMAN PAPILLOMAVIRUS; MIRIDAE; ORYCTOLAGUS CUNICULUS;

EID: 33846337051     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.08.037     Document Type: Article

References (25)

1. Baker T.S., Newcomb W.W., Olson N.H., Cowsert L.M., Olson C., and Brown J.C. Structures of bovine and human papillomaviruses: analysis by cryoelectron microscopy and three-dimensional image reconstruction. Biophys. J. 60 (1991) 1445-1456
2. Breitburd F., Kirnbauer R., Hubbert N.L., Nonnenmacher B., Trin-Dinh-Desmarquet C., Orth G., Schiller J.T., and Lowy D.R. Immunization with viruslike particles from cottontail rabbit papillomavirus(CRPV) can protect against experimental CRPV infection. J. Virol. 69 6 (1995) 3959-3963
3. Buck C.B., Pastrana D.V., Lowy D.R., and Schiller J.T. Efficient intracellular assembly of papillomaviral vectors. J. Virol. 78 2 (2004) 751-757
4. Crawford L.V., and Crawford E.M. A comparative study of polyoma papilloma viruses. Virology 21 (1963) 258-263
5. Embers M.E., Budgeon L.R., Pickel M., and Christensen N.D. Protective immunity to rabbit oral and cutaneous papillomaviruses immunization with short peptides of L2, the minor capsid protein. J. Virol. 76 19 (2002) 9798-9805
6. Ferlay J., Parkin D.M., and Pisani P. GLOBOCAN graphical package 1: cancer incidence and mortality worldwide (1998), IARC Press Lyon Electronic citation
7. Giroglou T., Sapp M., Lane C., Fligge C., Christensen N.D., Streeck R.E., and Rose R.C. Immunological analyses of human papillomavirus capsids. Vaccine. 19 (2001) 1783-1793
8. Harper D.M., Franco D.M., Wheeler C.M., Moscocki A.B., Romanoswski B., Roteli-Martins C.M., Jenkins D., Schuind A., Costa Clemens S.A., and Dubin G. HPV vaccine study group. 2006. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet 367 9518 (2006) 1247-1255
9. Heino P., Skyldberg B., Lehtinen M., Rarotala I., Hagmar B., Kreider J.W., Kirnbauer R., and Dillner J. Human papillomavirus type16 capsids expose multiple type-restricted and type common antigenic epitopes. J. Gen. Virol. 76 (1995) 1141-1153
10. Jones S.B. Cancer in the developing world: a call to action. BMJ 319 (1999) 505-508
11. Kawana K., Yoshikawa H., Taketani Y., and Kanda T. Common neutralizing epitope in minor capsid protein L2 of human papillomavirus Types 16 and 6. J. Virol. 73 3 (1999) 6188-6190
12. Kirnbauer R., Booy F., Cheng N., Lowy D.R., and Schiller J.T. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 12180-12184
13. Liu W.J., Gissman L., Sun X.Y., Kanjanahaluethai A., Muller M., Doorbar J., and Zhou J. Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type1 virions. Virology 227 (1997) 474-483
14. Munoz N., Bosch F.X., Castellsague X., Diaz M., Sanjose S., Hammouda D., Shah K.V., and Meijer C.J.L.M. Against which human papillomavirus types shall we vaccinate and screen?. Int. J. Cancer 111 (2004) 278-285
15. Pastrana D.V., Gambhira R., Buck C.B., Pang YY.S., Thompson C.D., Culp T.D., Christensen N.D., Lowy D.R., Schiller J.T., and Roden R.B.S. Cross-neutralization of cutaneous and mucosal papillomavirus types with anti-sera to the amino terminus of L2. Virology 337 2 (2005) 365-372
16. Roden R.B., Greenstone H.L., Kirnbauer R., Booy F.P., Jessie J., Lowy D.R., and Schiller J.T. In vitro generation and type-specific neutralization of a human papillomavirus type16 virion pseudotype. J. Virol. 70 (1996) 5875-5883
17. Roden R.B., Yutzy W.H., Fallon R., Inglis S., Lowy D.R., and Schiller J.T. Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes. Virology 270 (2000) 254-257
18. Stoler M.H. Human papillomaviruses and cervical neoplasia: a model for carcinogenesis. Int. J. Gynecol. Pathol. 19 (2000) 16-28
19. Stauffer Y., Raj K., Masternak K., and Beard P. Infectious human papillomavirus type18 pseudovirions. J. Mol. Biol. 283 (1998) 529-536
20. Suzich J.A., Ghim S.J., Palmer-hill F.J., White W.I., Tamura J.K., Bell J.A., Newsome J.A., Jenson A.B., and Schlegel R. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 11553-11557
21. Unckell F., Streeck R.E., and Sapp M. Generation and neutralization of pseudovirions of human papillomavirus type33. J. Virol. 71 (1997) 2934-2939
22. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., Wheeler C.M., Koutsky L.A., Malm C., Lehtinen M., Skjeldestad F.F., Olsson S.E., Steinwall M., Brown D.R., Kurman R.J., Ronnett B.M., Stoler M.H., Ferenczy A., Harper D.M., Tamms G.M., Yu J., Lupinacci L., Railkar R., Taddeo F.J., Jansen K.U., Esser M.T., Sings H.L., Saah A.J., and Barr E. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 6 5 (2005) 256-257
23. Zhao K.N., Sun X.Y., Frazer I.H., and Zhou J. DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1. Virology 243 (1998) 482-491
24. Zhou J., Sun X.Y., Stenzel D.J., and Frazer I.H. Expression of vaccinia recombinant HPV16L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like Particles. Virology 185 (1991) 251-257
25. Zhou J., Stenzel D.J., Sun X.Y., and Frazer I.H. Synthesis and assembly of infectious bovine papillomavirus particles in vitro. J. Gen. Virol. 74 (1993) 763-768